Avista Healthcare Partners Completes Sale of Solmetex to AGIC Capital
New Chapter for Solmetex with AGIC Capital Partnership
On March 19, 2025, Avista Healthcare Partners announced the successful sale of Solmetex, a leader in dental products and systems, to AGIC Capital, a global private equity firm focused on driving growth and innovation. This strategic transaction marks a significant milestone for Solmetex as it continues to expand its presence in the dental industry. While the terms of the sale remain undisclosed, Avista has retained a minority stake in the company to collaborate with AGIC Capital on Solmetex’s future growth trajectory.
Over the past four years, Solmetex has experienced remarkable progress under Avista’s ownership. With three strategic acquisitions—Sterisil, Dryshield, and Impladent—the company has greatly enhanced its product offerings. These acquisitions have allowed Solmetex to go beyond being the largest closed-loop dental amalgam waste compliance provider in North America and become a renowned multi-product provider specializing in dental waterline safety solutions, infection control, and advanced regenerative biomaterials.
Expressing gratitude for Avista’s support, Gene Dorff, CEO of Solmetex, highlighted the company’s growth and its evolving commitment to delivering high-quality dental consumables. “Avista has played an instrumental role in helping us expand our capabilities, and we are now thrilled to partner with AGIC Capital to further accelerate our mission. Their expertise aligns perfectly with our vision to drive innovation and provide superior products to dental professionals worldwide,” said Dorff.
AGIC Capital, an investment firm specializing in advanced healthcare and industrial technologies, will bring valuable resources and strategic insight to propel Solmetex in its next phase of growth. With their backing, Solmetex aims to continue pioneering cutting-edge solutions that align with regulatory compliance and customer needs in the dental field.
Representing Solmetex during the transaction, Robert W. Baird & Co. and Houlihan Lokey served as financial advisors, while Willkie Farr & Gallagher LLP advised Avista, and White & Case advised AGIC.
About Avista Healthcare Partners
Avista Healthcare Partners is a premier New York-based private equity firm founded in 2005, with a specialization in healthcare investments. With over $8 billion invested across 45 healthcare businesses, Avista focuses on high-growth opportunities in six key healthcare sub-sectors. Their commitment to fostering sustainable and scalable healthcare businesses has made them a trusted partner within the industry. Learn more about Avista at avistahealthcare.com.
About AGIC Capital
Founded in 2015, AGIC Capital invests in dynamic middle-market businesses specializing in advanced technologies in healthcare and industrial sectors. With $2.2 billion in assets under management and a team operating across Europe and Asia, AGIC is dedicated to fostering growth and creating long-term value. For more information, visit agic-group.com.
About Solmetex
Solmetex is a pioneer in dental amalgam waste compliance and developer of a broad portfolio of dental consumables and equipment. Known for its innovative amalgam separators, waterline safety solutions, and regenerative biomaterials, Solmetex delivers trusted and comprehensive environmental solutions for dental practices. Discover more at solmetex.com.
This transaction underscores the strength of strategic partnerships and the potential for growth and innovation in the healthcare and dental industries. Both Avista and AGIC’s investment reflects their focus on delivering sustainable solutions and driving progress in this vital sector.
